N James Topper

Affiliations

  • at Mbx Biosciences Inc. (MBX), 2024-09-18
  • Large Shareholder at Hillevax Inc. (HLVX), 2024-05-31
  • at Phathom Pharmaceuticals Inc. (PHAT), 2024-05-24
  • Director at Alpine Immune Sciences Inc. (ALPN), 2024-05-21
  • at Newamsterdam Pharma Co N.v. (NAMS), 2024-03-28
  • Large Shareholder at Arcutis Biotherapeutics Inc. (ARQT), 2023-10-26
  • Large Shareholder, Director at Anaptysbio Inc (ANAB), 2023-01-11
  • Chief Executive Officer at Frazier Lifesciences Acquisition Corp (FLAC), 2020-12-17
  • Large Shareholder, Director at Allena Pharmaceuticals Inc. (ALNA), 2020-11-18
  • Large Shareholder at Tarsus Pharmaceuticals Inc. (TARS), 2020-10-21
  • Director at Aptinyx Inc. (APTX), 2020-04-02
  • Large Shareholder at Passage Bio Inc. (PASG), 2020-03-03
  • Large Shareholder at Entasis Therapeutics Holdings Inc. (ETTX), 2020-01-13
  • Large Shareholder at Mirum Pharmaceuticals Inc. (MIRM), 2019-07-24
  • Large Shareholder, Director at Sierra Oncology Inc. (SRRA), 2017-02-16
  • Large Shareholder at Glaukos Corp (GKOS), 2015-06-30
  • Large Shareholder at Collegium Pharmaceutical Inc (COLL), 2015-05-14
  • Director at Amicus Therapeutics Inc (FOLD), 2014-06-16
  • Director at Portola Pharmaceuticals Inc (PTLA), 2013-06-07
  • Director at La Jolla Pharmaceutical Co (LJPC), 2009-02-26
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
NAMS $21.50 8,429 3,008,429 2024-03-26 Filing
FLAC $10.00 1,000,000 Officer, Director 1,000,000 2020-12-11 Filing
ALPN $5.37 372,439 Large Shareholder, Director 2,571,450 2019-01-18 Filing
ETTX $15.00 375,887 Large Shareholder, Director 1,349,953 2018-09-28 Filing
APTX $16.00 150,000 Large Shareholder, Director 3,190,079 2018-06-25 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ALPN $64.57 19 2,829,347 2024-04-25 Filing
LJPC $0.06 2,756,711 Director 0 2009-02-26 Filing
LJPC $0.06 1,454,000 Director 2,756,711 2009-02-25 Filing
LJPC $0.07 1,662,000 Director 4,210,711 2009-02-24 Filing